Inventor · disambiguated record
Sharon Hamm
Also filed as: HAMM SHARON
16 granted patents·7 pending applications·23 citations·filing 2005–2025
89Inventor score
Files withAMNEAL PHARMACEUTICALS LLC7SAOL INT DEVELOPMENT LTD5RECRO GAINESVILLE LLC3SAOL INTERNATIONAL LTD3REKHI GURVINDER S2
Top patents by PatentIndex Score
23 records- 0194US11491125B1Baclofen formulations and methods of minimizing patient exposure to metabolite variationsAMNEAL PHARMACEUTICALS LLC·Filed 2021·Granted Nov 8, 2022·3 cites·20 claims
- 0289US11654124B2Stabilized formulations of 4-amino-3-substituted butanoic acid derivativesAMNEAL PHARMACEUTICALS LLC·Filed 2020·Granted May 23, 2023·2 cites·13 claims
- 0388US10792262B1Stabilized formulations of 4-amino-3-substituted butanoic acid derivativesSAOL INTERNATIONAL LTD·Filed 2019·Granted Oct 6, 2020·7 cites·23 claims
- 0482US12383522B2Baclofen formulations and methods of minimizing patient exposure to metabolite variationsAMNEAL PHARMACEUTICALS LLC·Filed 2023·Granted Aug 12, 2025·0 cites·16 claims
- 0582US8992973B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideREKHI GURVINDER SINGH·Filed 2012·Granted Mar 31, 2015·5 cites·18 claims
- 0681US10434248B1Kit and method of reducing human error during implanted infusion pump refillingSAOL INTERNATIONAL LTD·Filed 2018·Granted Oct 8, 2019·6 cites·3 claims
- 0777US11850225B2Baclofen formulations and methods of minimizing patient exposure to metabolite variationsAMNEAL PHARMACEUTICALS LLC·Filed 2022·Granted Dec 26, 2023·0 cites·19 claims
- 0875US12011502B2Compositions and methods of administering baclofenAMNEAL PHARMACEUTICALS LLC·Filed 2022·Granted Jun 18, 2024·0 cites·12 claims
- 0975US11931328B2Stabilized formulations of 4-amino-3-substituted butanoic acid derivativesAMNEAL PHARMACEUTICALS LLC·Filed 2023·Granted Mar 19, 2024·0 cites·18 claims
- 1069US11083695B2Injectable phenol formulations and methods of manufactureSAOL INT DEVELOPMENT LTD·Filed 2021·Granted Aug 10, 2021·0 cites·19 claims
- 1169US11083694B2Injectable phenol formulations and methods of their useSAOL INT DEVELOPMENT LTD·Filed 2021·Granted Aug 10, 2021·0 cites·19 claims
- 1267US11523984B1Compositions and methods of administering baclofenAMNEAL PHARMACEUTICALS LLC·Filed 2021·Granted Dec 13, 2022·0 cites·14 claims
- 1365US10959962B2Injectable phenol formulations and methods of their useSAOL INT DEVELOPMENT LTD·Filed 2020·Granted Mar 30, 2021·0 cites·10 claims
- 1465US2019380969A1Controlled Release Compositions Comprising A Combination Of Isosorbide Dinitrate And Hydralazine HydrochlorideRECRO GAINESVILLE LLC·Filed 2019·Application pending·0 cites
- 1561US10213389B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideRECRO GAINESVILLE LLC·Filed 2016·Granted Feb 26, 2019·0 cites·6 claims
- 1659US9463166B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideRECRO GAINESVILLE LLC·Filed 2016·Granted Oct 11, 2016·0 cites·20 claims
- 1758US2007098796A1Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrlorideREKHI GURVINDER S·Filed 2005·Application pending·0 cites
- 1856US2012100209A1Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideREKHI GURVINDER SINGH·Filed 2011·Application pending·0 cites
- 1952US2025369974A1Method for monitoring and preventing clinically significant ketone levels in patients receiving dichloroacetate co-administered with a carbohydrate restricted dietSAOL INT DEVELOPMENT LTD·Filed 2025·Application pending·0 cites
- 2051US2007098791A1Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideREKHI GURVINDER S·Filed 2006·Application pending·0 cites
- 2150US9308177B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideRECRO TECHNOLOGY LLC·Filed 2015·Granted Apr 12, 2016·0 cites·21 claims
- 2250US2021128827A1Kit and method of reducing human error during implanted infusion pump refillingSAOL INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 2344US2025223628A1Methods of improving survival and eliminating treatment-limiting toxicities of dichloroacetate in patients with pyruvate dehydrogenase complex deficiencySAOL INT DEVELOPMENT LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sharon Hamm files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →